vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.
Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $85.1M, roughly 1.1× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 2.3%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 13.7%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
FDMT vs PACK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $93.7M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 39.0% |
| Operating Margin | 17.3% | -1.0% |
| Net Margin | 22.8% | — |
| Revenue YoY | 8508900.0% | 2.3% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $93.7M | ||
| Q3 25 | $90.0K | $83.6M | ||
| Q2 25 | $15.0K | $77.8M | ||
| Q1 25 | $14.0K | $77.6M | ||
| Q4 24 | $1.0K | $91.6M | ||
| Q3 24 | $3.0K | $78.6M | ||
| Q2 24 | $5.0K | $72.8M | ||
| Q1 24 | $28.0K | $72.5M |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $-56.9M | $-10.4M | ||
| Q2 25 | $-54.7M | $-7.5M | ||
| Q1 25 | $-48.0M | $-10.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-43.8M | $-8.1M | ||
| Q2 24 | $-35.0M | $5.5M | ||
| Q1 24 | $-32.4M | $-8.1M |
| Q4 25 | — | 39.0% | ||
| Q3 25 | — | 41.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 45.2% | ||
| Q3 24 | — | 43.8% | ||
| Q2 24 | — | 43.5% | ||
| Q1 24 | — | 44.6% |
| Q4 25 | 17.3% | -1.0% | ||
| Q3 25 | -67983.3% | -6.8% | ||
| Q2 25 | -396373.3% | -12.5% | ||
| Q1 25 | -383007.1% | -10.3% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | -1704400.0% | -5.3% | ||
| Q2 24 | -849120.0% | -7.1% | ||
| Q1 24 | -136200.0% | -6.6% |
| Q4 25 | 22.8% | — | ||
| Q3 25 | -63195.6% | -12.4% | ||
| Q2 25 | -364386.7% | -9.6% | ||
| Q1 25 | -342657.1% | -14.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1461433.3% | -10.3% | ||
| Q2 24 | -699060.0% | 7.6% | ||
| Q1 24 | -115717.9% | -11.2% |
| Q4 25 | $0.43 | $-0.11 | ||
| Q3 25 | $-1.01 | $-0.12 | ||
| Q2 25 | $-0.98 | $-0.09 | ||
| Q1 25 | $-0.86 | $-0.13 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.79 | $-0.10 | ||
| Q2 24 | $-0.63 | $0.07 | ||
| Q1 24 | $-0.66 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $63.0M |
| Total DebtLower is stronger | — | $401.9M |
| Stockholders' EquityBook value | $505.7M | $534.9M |
| Total Assets | $566.7M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.75× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $63.0M | ||
| Q3 25 | $305.1M | $49.9M | ||
| Q2 25 | $293.2M | $49.2M | ||
| Q1 25 | $321.4M | $65.5M | ||
| Q4 24 | $424.9M | $76.1M | ||
| Q3 24 | $501.9M | $69.5M | ||
| Q2 24 | $541.9M | $65.1M | ||
| Q1 24 | $525.9M | $55.1M |
| Q4 25 | — | $401.9M | ||
| Q3 25 | — | $403.1M | ||
| Q2 25 | — | $403.1M | ||
| Q1 25 | — | $405.2M | ||
| Q4 24 | — | $406.4M | ||
| Q3 24 | — | $403.2M | ||
| Q2 24 | — | $396.1M | ||
| Q1 24 | — | $396.7M |
| Q4 25 | $505.7M | $534.9M | ||
| Q3 25 | $369.0M | $537.8M | ||
| Q2 25 | $420.9M | $539.0M | ||
| Q1 25 | $469.7M | $544.1M | ||
| Q4 24 | $510.6M | $548.1M | ||
| Q3 24 | $552.9M | $564.3M | ||
| Q2 24 | $588.3M | $566.2M | ||
| Q1 24 | $600.6M | $560.0M |
| Q4 25 | $566.7M | $1.1B | ||
| Q3 25 | $424.0M | $1.1B | ||
| Q2 25 | $473.6M | $1.1B | ||
| Q1 25 | $515.7M | $1.1B | ||
| Q4 24 | $560.4M | $1.1B | ||
| Q3 24 | $604.0M | $1.1B | ||
| Q2 24 | $620.1M | $1.1B | ||
| Q1 24 | $629.9M | $1.1B |
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $19.5M |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $19.5M | ||
| Q3 25 | $-46.5M | $8.5M | ||
| Q2 25 | $-43.4M | $-3.6M | ||
| Q1 25 | $-47.8M | $-1.3M | ||
| Q4 24 | $-134.6M | $6.5M | ||
| Q3 24 | $-29.4M | $10.1M | ||
| Q2 24 | $-30.2M | $19.6M | ||
| Q1 24 | $-29.1M | $5.2M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | — | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | — | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | — | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | — | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — | ||
| Q1 24 | 2535.7% | — |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.56× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
